Bangladesh to get Indian COVID-19 vaccine on priority, says Harsh Vardhan Shringla

Shringla met Bangladeshi Prime Minister Sheikh Hasina on Tuesday during which they discussed ways to co-operate on containing the coronavirus pandemic, including on therapeutics and vaccine, sources said.;

Published On 2020-08-20 08:10 GMT | Update On 2021-08-12 11:57 GMT

Dhaka [Bangladesh]: Bangladesh will be a priority recipient for the Covid-19 vaccine developed in India according to foreign secretary Harsh Vardhan Shringla.

"For us, Bangladesh is always a priority country," Shringla who is on a two-day visit here quoted by local media as telling reporters here on Wednesday on being asked about the vaccines.

Dhaka today said it is ready to hold trials of the potential Covid-19 vaccines being developed by India.

The proposal was made during a meeting between Shringla and his Bangladesh counterpart Masud Bin Momen at Hotel Sonargaon here.

"We offered that we can extend our assistance, if needed, especially in terms of a vaccine trial, we are ready," Bangladesh's Daily Star quoted Momen as saying.

Momen said that the Indian side positively responded, saying that they are developing vaccines not only for themselves but also for others and that Bangladesh will get priority.

Momen also said that Bangladesh has a good number of pharmaceutical companies with the capacity of vaccine production.

"We sought their cooperation in creating collaboration to that end," he said.

Clinical trials of two COVID-19 vaccines developed in India are underway.

The Phase-2 human clinical trials of two COVID-19 vaccines developed indigenously by Bharat Biotech in collaboration with ICMR and

Zydus Cadila Ltd are currently underway in India.

Shringla met Bangladeshi Prime Minister Sheikh Hasina on Tuesday during which they discussed ways to co-operate on containing the coronavirus pandemic, including on therapeutics and vaccine, sources said.

Shringla is on his two-day visit to Bangladesh. He reached Dhaka on Tuesday in his first foreign visit since the COVID-19 pandemic outbreak.

Read also:
Dr Reddys Unveils COVID Drug Favipiravir Under Brand Name AVIGAN In India

Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bangladesh to get Indian COVID-19 vaccine on priority, says Harsh Vardhan Shringla

Shringla met Bangladeshi Prime Minister Sheikh Hasina on Tuesday during which they discussed ways to co-operate on containing the coronavirus pandemic, including on therapeutics and vaccine, sources said.;

Similar News

Novartis, Monte Rosa Therapeutics join hands for Degraders to treat Immune-mediated diseases

ZyVet releases generic treatment for Canine Urinary Incontinence in US

Keeping Medicines Without Licence Amounts to 'Offer for Sale', HC Upholds Chemist's Conviction

Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil

Zydus Foundation Vice Chairperson Meha Patel appointed as Member of CII National Committee on Art & Culture for 2025-26

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC

Delhi to form special committee to crush fake medicine racket

Roche Pharma teams up with 10 Govt Hospitals to power up clinical trial capacities in India